Table 2. Relationship between living and deceased patients’ age, clinical follow-up period and laboratory parameters measured on the 0th and 10th days.
| Characteristics | All patients | Ex-patients | Alive patients | P value | ||||
|---|---|---|---|---|---|---|---|---|
| Age | 67.0 (58.0–77.0) | 70 (61–79) | 62 (51–71) | < 0.001 | ||||
| Antibiotic duration, day | 12.0 (8.0–17.0) | 13 (10–17) | 10 (8–16) | 0.002 | ||||
| Sedation duration, day | 9.0 (3.0–15.0) | 11 (7–16) | 10 (5–20) | 0.586 | ||||
| MV duration, day | 9.0 (3.0–15.0) | 11 (7–16) | 11 (5–21) | 0.882 | ||||
| ICU length of stary, day | 13.0 (10.0–19.0) | 13 (10–19) | 12 (9–18) | 0.020 | ||||
| Laboratory parameters | Day 0 | Day 10 | Day 0 | Day 10 | Day 0 | Day 10 | ||
| P/F ratio | 116.8 (90.0–160.5) | 140.0 (100.0–200.0) | 110 (85–162) | 120 (90–160) | 120 (100–161) | 200 (150–280) | < 0.001 | |
| SOFA score | 4.0 (3.0–7.0) | 7.0 (4.0–10.0) | 5 (3–8) | 9 (6–11) | 4 (3–6) | 3 (2–6) | < 0.001 | |
| D-dimer, µg/L | 1,190.0 (668.0–2,500.0) | 1,863.5 (927.5–3,900.0) | 1,250 (683–2,783) | 2,290 (1,195–4,675) | 1,030 (635–2,200) | 1,160 (595–2,205) | < 0.001 | |
| Ferritin, µg/L | 618.0 (314.0–1,146.5) | 669.0 (340.5–1,316.0) | 653 (330–1,178) | 849 (422–1,605) | 536 (297–1,031) | 436 (219–730) | < 0.001 | |
| Lymphocyte, µg/L | 680.0 (440.0–1,010.0) | 700.0 (400.0–1,172.5) | 670 (430–1,000) | 600 (350–1,025) | 710 (460–1,050) | 900 (600–1,315) | < 0.001 | |
| CRP, mg/L | 114.0 (61.0–177.0) | 82.5 (26.0–158.0) | 116 (68–182) | 109 (55–196) | 107 (54–173) | 28 (8–79) | < 0.001 | |
| Fibrinogen, mg/L | 568.5 (455.0–698.0) | 508.0 (366.3–660.5) | 567 (458–698) | 532 (377–700) | 570 (451–693) | 450 (350–570) | < 0.001 | |
Values are presented as median (Q1–Q3).
MV = mechanical ventilation, ICU = intensive care unit, P/F = PaO2/FiO2, SOFA = Sofa Sequential Organ Failure Assessment, CRP = C-reactive protein.